Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Lena Tiomkin"'
Autor:
Arnon Nagler, Avichai Shimoni, Izhar Hardan, Orly Eizenberg, Howard Laurence Shaw, Eithan Galun, Sigal Aviel, Yaron Ramati, Yossi Riback, Lena Ribakovsky, Lena Tiomkin, Hanna Wald, Katia Beider, Jacob M. Rowe, Irit Avivi, Michal Abraham, Amnon Peled
Purpose: CXCR4 plays an important role in the retention of stem cells within the bone marrow. BKT140 (4F-benzoyl-TN14003) is a 14-residue bio stable synthetic peptide, which binds CXCR4 with a greater affinity compared with plerixafor (4 vs. 84 nmol/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07d5703b75834795cdad6e5e3137fbc2
https://doi.org/10.1158/1078-0432.c.6521523.v1
https://doi.org/10.1158/1078-0432.c.6521523.v1
Autor:
Avichai Shimoni, Orly Eizenberg, Sigal Aviel, Katia Beider, Lena Tiomkin, Yossi Riback, Arnon Nagler, Jacob M. Rowe, Yaron Ramati, Howard Laurence Shaw, Lena Ribakovsky, Eithan Galun, Irit Avivi, Amnon Peled, Hanna Wald, Michal Abraham, Izhar Hardan
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 20(2)
Purpose: CXCR4 plays an important role in the retention of stem cells within the bone marrow. BKT140 (4F-benzoyl-TN14003) is a 14-residue bio stable synthetic peptide, which binds CXCR4 with a greater affinity compared with plerixafor (4 vs. 84 nmol/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::100d695b90e0da6cbbec071e14a2c235
https://pubmed.ncbi.nlm.nih.gov/24246358
https://pubmed.ncbi.nlm.nih.gov/24246358
